Literature DB >> 32922003

Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect.

Enrui Chen1, Shangcong Han1, Bo Song2, Lisa Xu1, Haicheng Yuan2, Mingtao Liang3, Yong Sun1.   

Abstract

BACKGROUND: Hyaluronic acid (HA) is a major component of extracellular matrix (ECM) and its over expression in tumor tissues contributes to the increase of interstitial fluid pressure (IFP) and hinders the penetration of nanoparticles into solid tumors.
MATERIALS AND METHODS: We here reported a tumoral microenvironment responsive multistage drug delivery system (NPs-EPI/HAase) which was formed layer by layer via electrostatic interaction with epirubicin (EPI)-loaded PEG-b-poly(2-(diisopropylamino)ethyl methacrylate)-b-poly(2-guanidinoethylmethacrylate) (mPEG-PDPA-PG, PEDG) micelles (NPs-EPI) and hyaluronidase (HAase). In this paper, we focused on the hyaluronidase-combined nanoparticles (NPs-EPI/HAase) for tumor penetration in tumor spheroid and solid tumor models in vitro and in vivo.
RESULTS: Our results showed that NPs-EPI/HAase effectively degrade the HA in ECM and facilitate deep penetration of NPs-EPI into solid tumor. Moreover, NPs-EPI mainly employed clathrin-mediated and macropinocytosis-mediated endocytic pathways for cellular uptake and were subsequently directed to the lysosomes for further drug release triggered by proton sponge effect. Compared with NPs-EPI, the HAase coating group showed an enhanced tumoral drug delivery efficacy and inhibition of tumor growth.
CONCLUSION: Overall, our studies demonstrated that coating nanoparticles with HAase can provide a simple but efficient strategy for nano-drug carriers to enhance solid tumor penetration and chemotherapeutic efficacy.
© 2020 Chen et al.

Entities:  

Keywords:  ECM; hyaluronidase; nanoparticles; tumor penetration

Mesh:

Substances:

Year:  2020        PMID: 32922003      PMCID: PMC7458542          DOI: 10.2147/IJN.S257164

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  45 in total

1.  Sequentially Responsive Shell-Stacked Nanoparticles for Deep Penetration into Solid Tumors.

Authors:  Jinjin Chen; Jianxun Ding; Yucai Wang; Jianjun Cheng; Shengxiang Ji; Xiuli Zhuang; Xuesi Chen
Journal:  Adv Mater       Date:  2017-06-20       Impact factor: 30.849

2.  Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts.

Authors:  Live Eikenes; Ingunn Tufto; Edrun A Schnell; Astrid Bjørkøy; Catharina De Lange Davies
Journal:  Anticancer Res       Date:  2010-02       Impact factor: 2.480

3.  Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy.

Authors:  Hao Zhou; Zhiyuan Fan; Junjie Deng; Pelin K Lemons; Dimitrios C Arhontoulis; Wilbur B Bowne; Hao Cheng
Journal:  Nano Lett       Date:  2016-04-08       Impact factor: 11.189

4.  cRGD/TAT Dual-Ligand Reversibly Cross-Linked Micelles Loaded with Docetaxel Penetrate Deeply into Tumor Tissue and Show High Antitumor Efficacy in Vivo.

Authors:  Yaqin Zhu; Jian Zhang; Fenghua Meng; Chao Deng; Ru Cheng; Jan Feijen; Zhiyuan Zhong
Journal:  ACS Appl Mater Interfaces       Date:  2017-10-06       Impact factor: 9.229

5.  Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look.

Authors:  Clifford J Whatcott; Haiyong Han; Richard G Posner; Galen Hostetter; Daniel D Von Hoff
Journal:  Cancer Discov       Date:  2011-09       Impact factor: 39.397

6.  The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis.

Authors:  N Kee; S Sivalingam; R Boonstra; J M Wojtowicz
Journal:  J Neurosci Methods       Date:  2002-03-30       Impact factor: 2.390

Review 7.  Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression.

Authors:  Naoki Itano; Lisheng Zhuo; Koji Kimata
Journal:  Cancer Sci       Date:  2008-06-28       Impact factor: 6.716

Review 8.  Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.

Authors:  Virginia M Platt; Francis C Szoka
Journal:  Mol Pharm       Date:  2008-06-03       Impact factor: 4.939

9.  Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma.

Authors:  Daniela Pankova; Yulong Chen; Masahiko Terajima; Mark J Schliekelman; Brandi N Baird; Monica Fahrenholtz; Li Sun; Bartley J Gill; Tegy J Vadakkan; Min P Kim; Young-Ho Ahn; Jonathon D Roybal; Xin Liu; Edwin Roger Parra Cuentas; Jaime Rodriguez; Ignacio I Wistuba; Chad J Creighton; Don L Gibbons; John M Hicks; Mary E Dickinson; Jennifer L West; K Jane Grande-Allen; Samir M Hanash; Mitsuo Yamauchi; Jonathan M Kurie
Journal:  Mol Cancer Res       Date:  2015-12-02       Impact factor: 5.852

10.  Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts.

Authors:  L Eikenes; M Tari; I Tufto; O S Bruland; C de Lange Davies
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

View more
  4 in total

Review 1.  Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments.

Authors:  Seungyong Shin; Jiyoung Lee; Jieun Han; Fangyuan Li; Daishun Ling; Wooram Park
Journal:  Tissue Eng Regen Med       Date:  2021-10-21       Impact factor: 4.451

Review 2.  Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines.

Authors:  Meng Li; Yijing Zhang; Qin Zhang; Jingchao Li
Journal:  Mater Today Bio       Date:  2022-07-15

3.  Chemosensitivity enhanced by autophagy inhibition based on a polycationic nano-drug carrier.

Authors:  Na Li; Shangcong Han; Baohua Ma; Xia Huang; Lisa Xu; Jie Cao; Yong Sun
Journal:  Nanoscale Adv       Date:  2021-01-27

Review 4.  Bioenzyme-based nanomedicines for enhanced cancer therapy.

Authors:  Mengbin Ding; Yijing Zhang; Jingchao Li; Kanyi Pu
Journal:  Nano Converg       Date:  2022-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.